While Talaris Therapeutics is ending two clinical tests of its cell therapy in kidney transplant patients, a third study in the autoimmune condition scleroderma is continuing. Meanwhile, the biotech’s restructuring plan is pursuing “strategic alternatives” that could include a merger or sale.
Three biotechs IPOs priced this week while one gene therapy developer postponed its plans. The biggest IPO belongs to Talaris Therapeutics, a company developing a cell therapy for organ transplant patients that could mean the end of lifelong immunosuppressive drugs that prevent rejection.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The insurer picked digital health startup Vida to offer a virtual diabetes management program for Medicaid patients in Kentucky.
Molina will acquire Passport Health Plan’s Medicaid and dual-eligible business for $20 million. The Kentucky-based company is a long-standing provider of Medicaid managed care plans, but lost a bid with the state earlier this year.
Transition to new payment models is also spurring provider investments in staff and technology, including data analytics, according to a new report from the insurer.
Humana alleges that Mallinckrodt illegally jacked up the price of the injected drug Acthar, causing the insurance company to pay several times more for the drug - which the FDA approved in 1952 - than it otherwise would have.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The deal leaves Bain Capital with a minority stake in the company and values Waystar at $2.7 billion.
The so-called Destination: Health network will launch later this year with Aetna Medicaid members in Louisville, Kentucky and Aetna dual-eligible special needs plan members in Tampa, Florida and Southeastern Louisiana.
Earlier this year, Bloomberg News reported that Bain Capital was considering a sale of Waystar with Oracle and Visa named as two potential acquirers.
While the policy has not yet gone into effect in Kentucky, data from the Arkansas Department of Human Services found that more than 18,000 people in the state have lost coverage due to the work requirements that were first introduced last year.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Under the terms of the deal, select Humana Medicare Advantage HMO plan and dual-eligible members in Southern and Central California will have in-network access to Heritage Provider Network's facilities and physician practices.
The startups in the accelerator's fall 2018 cohort, which will go through a 13-week program, are bringing their expertise to a plethora of areas in healthcare, including education, nursing homes, athletics and NICUs.
The 60-page ruling, which is likely to be appealed, was hailed by advocates for the poor. But it could limit the number of states expanding Medicaid under the Affordable Care Act.
Busy Burr leads the innovation team in Palo Alto for Humana. In an expansive phone interview, she talks about parallels between improv and innovation, what true partnership means and where Humana is looking to change healthcare.
In a recent phone interview, Humana CMO Dr. Roy Beveridge chatted about value-based care, social determinants of health, 2018 predictions and what the Louisville, Kentucky-based payer has been up to.